Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
2019 | journal article; research paper. A publication with affiliation to the University of Göttingen.
Jump to:Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
Brendel, M.; Deussing, M.; Blume, T.; Kaiser, L.; Probst, F.; Overhoff, F. & Peters, F. et al. (2019)
Alzheimer's Research & Therapy, 11(1). DOI: https://doi.org/10.1186/s13195-019-0522-z
Documents & Media
Details
- Authors
- Brendel, Matthias; Deussing, Maximilian; Blume, Tanja; Kaiser, Lena; Probst, Federico; Overhoff, Felix; Peters, Finn; von Ungern-Sternberg, Barbara; Ryazanov, Sergey ; Leonov, Andrei ; Griesinger, Christian ; Zwergal, Andreas; Levin, Johannes; Bartenstein, Peter; Yakushev, Igor; Cumming, Paul; Boening, Guido; Ziegler, Sibylle; Herms, Jochen; Giese, Armin; Rominger, Axel
- Issue Date
- 2019
- Journal
- Alzheimer's Research & Therapy
- Project
- EXC 2067: Multiscale Bioimaging
- Working Group
- RG Griesinger
- External URL
- https://mbexc.uni-goettingen.de/literature/publications/25
- Language
- English
